等待開盤 09-20 09:30:00 美东时间
+0.500
+2.94%
Shares of Inhibrx Biosciences (NASDAQ:INBX) added ~8% on Friday after its Chief Executive Officer, Mark Lappe, disclosed the purchase of 40K shares of the company’s common stock. The transaction condu...
08-23 22:01
Inhibrx Biosciences (NASDAQ:INBX) reported quarterly earnings of $125.48 per share. This is a 3011.37 percent increase over losses of $(4.31) per share from the same period last year. The company reported $100.00
08-14 15:24
Inhibrx Biosciences Inc : Jefferies Cuts Target Price to $11 From $35
08-14 11:51
Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Co...
08-14 06:55
JMP Securities analyst Reni Benjamin initiates coverage on Inhibrx Biosciences (NASDAQ:INBX) with a Market Perform rating.
07-23 18:32